Processing

Please wait...

Settings

Settings

Goto Application

1. WO2018129332 - EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES (TILS) WITH TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY (TNFRSF) AGONISTS AND THERAPEUTIC COMBINATIONS OF TILS AND TNFRSF AGONISTS

AU2018205234Expansion of tumor infiltrating lymphocytes (TILs) with tumor necrosis factor receptor superfamily (TNFRSF) agonists and therapeutic combinations of TILs and TNFRSF agonists
Appl.Date 05.01.2018
Appl.No 2018205234 Applicant Iovance Biotherapeutics, Inc. Related Type IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Kind A,A1
Pub.Date 12.07.2018
KR1020190104048종양 괴사 인자 수용체 슈퍼패밀리 (TNFRSF) 효능제를 사용한 종양 침윤 림프구 (TIL)의 확장 및 TIL과 TNFRSF 효능제의 치료 조합물
Appl.Date 05.01.2018
Appl.No 1020197022673 Applicant 이오반스 바이오테라퓨틱스, 인크. Related Type IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Kind A
Pub.Date 05.09.2019
EP3565888EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES (TILS) WITH TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY (TNFRSF) AGONISTS AND THERAPEUTIC COMBINATIONS OF TILS AND TNFRSF AGONISTS
Appl.Date 05.01.2018
Appl.No 18702378 Applicant IOVANCE BIOTHERAPEUTICS INC Related Type IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Kind A1 Pub.Lang en
Pub.Date 13.11.2019
CN110462027EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES (TILS) WITH TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY (TNFRSF) AGONISTS AND THERAPEUTIC COMBINATIONS OF TILS AND TNFRSF AGONISTS
Appl.Date 05.01.2018
Appl.No 201880016250.0 Applicant IOVANCE BIOTHERAPEUTICS INC. Related Type IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Kind A
Pub.Date 15.11.2019
EA201991657 РАЗМНОЖЕНИЕ ИНФИЛЬТРИРУЮЩИХ ОПУХОЛЬ ЛИМФОЦИТОВ (TIL) С ПОМОЩЬЮ АГОНИСТОВ НАДСЕМЕЙСТВА РЕЦЕПТОРОВ ФАКТОРА НЕКРОЗА ОПУХОЛИ И ТЕРАПЕВТИЧЕСКИЕ КОМБИНАЦИИ TIL И АГОНИСТОВ TNFRSF
Appl.Date 05.01.2018
Appl.No 201991657 Applicant АЙОВЭНС БАЙОТЕРАПЬЮТИКС, ИНК. Related Type IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Kind A1
Pub.Date 21.01.2020
BR112019013940método de tratar um câncer com uma população de linfócitos infiltrantes de tumor, processo para preparação de uma população de linfócitos infiltrantes de tumor, população de linfócitos infiltrantes de tumor, e, composição farmacêutica.
Appl.Date 05.01.2018
Appl.No 112019013940 Applicant IOVANCE BIOTHERAPEUTICS, INC. Related Type IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Kind A2
Pub.Date 11.02.2020
US20200121719EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES (TILS) WITH TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY (TNFRSF) AGONISTS AND THERAPEUTIC COMBINATIONS OF TILS AND TNFRSF AGONISTS
Appl.Date 05.01.2018
Appl.No 16475924 Applicant Iovance Biotherapeutics, Inc. Related Type IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Kind A1
Pub.Date 23.04.2020
JP2020514289腫瘍壊死因子受容体スーパーファミリー(TNFRSF)アゴニストによる腫瘍浸潤リンパ球(TIL)の拡大培養及びTILとTNFRSFアゴニストとの治療的併用
Appl.Date 05.01.2018
Appl.No 2019536214 Applicant アイオバンス バイオセラピューティクス,インコーポレイテッド Related Type IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Kind A Pub.Lang ja
Pub.Date 21.05.2020
WO/2018/129332EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES (TILS) WITH TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY (TNFRSF) AGONISTS AND THERAPEUTIC COMBINATIONS OF TILS AND TNFRSF AGONISTS
Appl.Date 05.01.2018
Appl.No PCT/US2018/012605 Applicant IOVANCE BIOTHERAPEUTICS, INC. Related Type IC1
PCT application from which the family originated.
Pub.Kind A Pub.Lang en
Pub.Date 12.07.2018
NZ754521EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES (TILS) WITH TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY (TNFRSF) AGONISTS AND THERAPEUTIC COMBINATIONS OF TILS AND TNFRSF AGONISTS
Appl.Date 12.06.2019
Appl.No 754521 Applicant IOVANCE BIOTHERAPEUTICS, INC. Related Type IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Kind A1 Pub.Lang en
Pub.Date 28.06.2019
IL267780EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES (TILS) WITH TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY (TNFRSF) AGONISTS AND THERAPEUTIC COMBINATIONS OF TILS AND TNFRSF AGONISTS
Appl.Date 01.07.2019
Appl.No 267780 Applicant IOVANCE BIOTHERAPEUTICS, INC. Related Type IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Kind A Pub.Lang en
Pub.Date 26.09.2019
MX2019007963EXPANSION DE LINFOCITOS INFILTRANTES DE TUMOR (TIL) CON AGONISTAS DE LA SUPERFAMILIA DE RECPTOR DE FACTOR DE NECROSIS TUMORAL (TNFRSF) Y COMBINACIONES TERAPEUTICAS DE TIL- Y AGONISTAS DE TNFRSF.
Appl.Date 01.07.2019
Appl.No 2019007963 Applicant IOVANCE BIOTHERAPEUTICS, INC. Related Type IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Kind A
Pub.Date 21.10.2019
CA3049163EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES (TILS) WITH TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY (TNFRSF) AGONISTS AND THERAPEUTIC COMBINATIONS OF TILS AND TNFRSF AGONISTS
Appl.Date 02.07.2019
Appl.No 3049163 Applicant IOVANCE BIOTHERAPEUTICS, INC. Related Type IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Kind A1 Pub.Lang en
Pub.Date 12.07.2018
IN201917031346EXPANSION OF TUMOR INFILTRATING LYMPHOCYTES (TILS) WITH TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY (TNFRSF) AGONISTS AND THERAPEUTIC COMBINATIONS OF TILS AND TNFRSF AGONISTS
Appl.Date 02.08.2019
Appl.No 201917031346 Applicant IOVANCE BIOTHERAPEUTICS, INC. Related Type IC2
National entry of a PCT application.

If this application is not visible in the National Phase tab of the PCT application, its relationship to the PCT application is identified from the PCT or regional filing or publication information of its bibliographic data.

Pub.Kind A Pub.Lang en
Pub.Date 06.09.2019